On 7 May 2026, Miracle Medicine Sdn Bhd and Guangdong Pharmaceutical University jointly announced peer-reviewed Porcupine Bezoar research findings and signed a new scientific collaboration — covered by 100+ Chinese media platforms including CCTV.com and Yangcheng Evening News.
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Porcupine Bezoar is a traditional health supplement, not a medicine. For all health-related decisions, please consult a registered healthcare professional.
On 7 May 2026, Miracle Medicine Sdn Bhd and Guangdong Pharmaceutical University jointly held a research results press conference and strategic collaboration signing ceremony in Guangzhou, China. The event officially announced the findings of the Porcupine Bezoar immunomodulatory study — published in Pharmaceuticals (MDPI) on 1 April 2026 — one of the most systematic peer-reviewed academic studies on Porcupine Bezoar to date. On the same day, both parties signed a new research collaboration agreement led by Dr Xue Xiao. The event received simultaneous coverage from over 100 Chinese media platforms, including CCTV.com and Yangcheng Evening News.
achieved in one day
with simultaneous coverage
with GDPU began
published internationally
Research Announced: Porcupine Bezoar Immunomodulatory Study
Press Conference: Immunomodulatory Effects of Porcupine Bezoar Study
The research team of Professor Xue Xiao from Guangdong Pharmaceutical University, together with Miracle Medicine Sdn Bhd, conducted a systematic investigation into the immunomodulatory properties of Porcupine Bezoar, applying multi-omics technologies to systematically analyse its immune-related pathways — providing important scientific reference material for consumers and healthcare professionals alike.
Yangcheng Evening News described the findings as Porcupine Bezoar receiving its “scientific identity card” for entering the modern medical system.
Read the Immunomodulatory Research Details →The Immunomodulatory Effects of Porcupine Bezoar on Cyclophosphamide-Induced Immunosuppression in Rats
Pharmaceuticals 2026, 19(4), 563 · Published 1 April 2026 · MDPI Open Access
Authors include: Kien-Seng Lim (Miracle Medicine), Xiao-Qing Sim (Miracle Medicine), Xue Xiao* (Guangdong Pharmaceutical University) et al.
doi.org/10.3390/ph19040563 →This academic study provides scientific reference material on Porcupine Bezoar. Research findings are for informational purposes only and do not constitute any health claim or medical advice. Please consult a registered healthcare professional before using any health supplement.
Systematic Research
Multi-omics technology applied to systematically investigate Porcupine Bezoar’s immune-related pathway mechanisms.
International Journal
Published in MDPI Pharmaceuticals, Open Access — freely readable and citable worldwide.
Guangdong Pharmaceutical University
Leading Chinese pharmaceutical university with authority in traditional Chinese medicine research.
Scientific Reference
One of the most systematic peer-reviewed academic references on Porcupine Bezoar currently available.
New Research Collaboration Signed: Further Scientific Exploration
New Scientific Research Collaboration Agreement Signed & Project Launched
On 7 May 2026, Miracle Medicine Sdn Bhd and Guangdong Pharmaceutical University formally signed a new research agreement, launching a new scientific investigation into the properties and mechanisms of Porcupine Bezoar, led by Dr Xue Xiao — further deepening the systematic scientific exploration of this traditional health supplement.
Dr Xue Xiao is an associate researcher at Guangdong Pharmaceutical University who was commended by the Guangdong Provincial Government in January 2026 for advancing industry-technology integration. Since 2019, Dr Xiao’s team has been studying Porcupine Bezoar’s scientific properties in collaboration with Miracle Medicine, working to bring rigorous academic research to the field of traditional health supplements.
“We want to use scientific research to provide consumers with a clearer, more transparent reference foundation — so that everyone can make an informed decision based on scientific evidence.”
CCTV Dialogue with National Brands: Partnership Signed
China Central Television’s Dialogue with National Brands — Partnership Signing
Miracle Medicine Sdn Bhd officially completed a partnership signing with CCTV’s Dialogue with National Brands programme. Prior to the signing, CCTV’s production team was specially dispatched from Beijing to Malaysia and Indonesia to conduct on-site filming of Miracle Medicine’s Porcupine Bezoar operations — from retail to raw material origins. Broadcast date to be announced.
🎬 Behind the Scenes: CCTV Filming in Malaysia & Indonesia
The following clips offer a behind-the-scenes look at the CCTV production team’s on-location filming:
CCTV filming — behind the scenes (I)
CCTV filming — behind the scenes (II)
What This Research Means for Singapore Consumers
For Singapore consumers, this peer-reviewed publication represents one of the most credible scientific references currently available on Porcupine Bezoar — providing a transparent, evidence-based foundation for those seeking to understand this traditional health supplement.
Miracle Medicine Singapore
26 Sin Ming Ln, #03-124 Midview City, Singapore 573971
Website: miraclemedicine.com.sg
Legally Available
Porcupine Bezoar is a traditional health supplement legally available for purchase in Singapore.
International Certifications
KKM, JAKIM HALAL, MeSTI, HACCP, GMP, ISO 9001:2015, ISO 22000:2018.
Scientific Reference
Peer-reviewed international journal publication providing transparent academic reference for consumers.
Consult a Professional
Always consult a registered healthcare professional before using any health supplement.
Academic research findings are for scientific reference only and do not represent medical advice or health claims. Consumers should consult a registered healthcare professional and consider their individual health circumstances before making any decisions.
Media Coverage: 100+ Chinese Platforms Simultaneously
⭐ Key Media Coverage
CCTV.com — University-Enterprise Collaboration: Porcupine Bezoar Set to Enter Modern Medical System (May 2026) Yangcheng Evening News — Southeast Asia’s “Rainforest King” Gets Scientific Backing (May 2026) Guangdong Education Online — Joint Research Results Announced (May 2026) Kan Nanyue — Porcupine Bezoar’s “Scientific Identity” (May 2026) Scholat — Research Results Coverage (May 2026) Science Net China — Research Results Coverage (May 2026)This event received simultaneous coverage from over 100 Chinese media platforms.
